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ABSTRACT
The  present  study  was  conducted  to  evaluate  the  effect  of  fermented  chub  mackerel  extract
(FCME) on lipid metabolism in diabetic rats.  Four week-old male Wistar rats were divided into three
groups based on weight. All rats were induced with diabetes mellitus by single intraperitoneal injection
of  streptozotocin  at  45  mg/kg  body  weight.  Thereafter,  they  were  randomly  distributed  to  three
treatments with 7 rats assigned to each treatment. One group was the control with no additive, and two-
treatment groups  were given  the purified diets  supplemented  with 1% or  2% FCME. Experimental
results showed that in comparison to the control, diabetic rats fed FCME increased feed intake (P<0.01)
and body weight  gain  (P<0.05).  FCME inclusion  significantly reduced the activities  of  acetyl-CoA
carboxylase (P<0.01) and fatty acid synthetase (P<0.05) in diabetic rats. FCME significantly increased
cholesterol 7  -hydroxylase with no effect on HMG-CoA reductase activity. FCME had no effect on
hepatic  triglyceride,  free  cholesterol  and  phospholipid.  FCME  inclusion  at  1%  level  significantly
reduced serum triglyceride. FCME significantly increased HDL-cholesterol (P<0.05) with no effect on
LDL + VLDL-cholesterol,  and significantly  reduced atherogenic index.  FCME did not  significantly
affect  serum insulin  and glucose concentration.  In  conclusion,  FCME supplementation altered lipid
metabolism in diabetic rats. FCME supplementation reduced the risk of atherosclerosis in diabetic rats. 
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INTRODUCTION
Diabetic mellitus is a state of nutritional state
of  nutritional starvation which frequently results
in  severe metabolic  imbalance  and pathological
change  in  many  tissues  (Inui  et  al.,  2000).  In
relation to lipid metabolism, diabetic condition is
characterized  by  increases  both  fatty  acid  and
cortisol. Consequently this could account for why
VLDL secretion  is  increased  in  ketotic  type  I
diabetes,  which  is  caused  by  insulin  deficiency
(Brindley, 1991). Hypersecretion of VLDL cause
hypertriglyceridemia. Other dyslipidemia includes
low HDL-cholesterol, and small, dense LDL. The
incidence of atherosclerosis is 3-4 times greater in
diabetics than non-diabetics at comparable plasma
total  cholesterol.  Beyond  total  cholesterol
concentration, lipid abnormalities in the plasma of
diabetics  include  elevated  triglyceride,  decrease
HDL-c  levels,  and  the  presence of  small  dense
LDL. Dixon et al. (2002) found that  the diabetic
swine had a higher   and broader IDL/LDL peak
and  a  significant   higher  LDL/HDL-c  ratio.
Furthermore,  they  stated  that  the  difference  in
lipoprotein  profile  per  se  may  be  the  cause  of
increased  atherosclerosis  in  diabetic  swines.  In
addition, the lack of insulin action combined with
the  effect   of  glucocorticoids  also  the  LDL
receptor  in the liver  (Schneider,  1991)  resulting
lower removing the major proportion of IDL and
LDL  from  the  circulation  leading  to
hypercholesterolemia.  Duchateau et  al. (2000)
found  that  there  was  significantly  increases  in
plasma apo L level, cholesterol and triglyceride in
subjects with type II diabetes.
Some investigations have been conducted  to
lower  obesity  in  diabetic  animals.  Dixon  et  al.
(2002)  found  that  atorvastatin  (80  mg/day)
inclusion  protected  diabetic  swine  against
coronary  artery  atherosclerosis.  This  protection
was in part caused by reduced plasma triglyceride
concentration  since  other  lipid  parameters,
inclusing  the  LDL/HDL  ratio  had  not  been
affected. Georgopoulos  et al. (1998) found that a
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high monounsaturated fatty-acid enriched diet  is
not  preferable  to  a  high-carbohydrate  diet  in
patients with type 1 Diabetes mellitus with regard
to the occurrence of postprandial lipemia. Higashi
et al. (2002) found that  oleic acid enriched diet
was associated with increased formation of post-
prandial chylomicron remnants compared with the
linoleic acid enriched diet in patients with type 2
Diabetes  mellitus.  We  recently  found  that
fermented chub mackerel extract was effective to
reduce lipid profiles in growing chicks (Tanaka et
al., 1990), broiler chicks (Tanaka et al., 1992) and
rats (Santoso  et al., 2000; 2001). This FCME was
known  to  be  rich  in  peptides.  Peptides  were
known  to  promote   cholesterol  efflux  from
cholesterol-enriched  cells,   activate  the  plasma
LCAT   and  to  protect  against  atherosclerosis
(Garber  et al., 2001). Therefore,  it  was assumed
that  FCME  inclusion  to  the  diet  would  reduce
lipid  profiles  in  diabetic  animals.  Therefore,  the
present study was conducted to evaluate effect of
FCME on lipid metabolism in diabetic rats.
MATERIALS AND METHODS
Twenty  one  of  four  week-old  male Wistar
rats  (body  weight  110+10  g)  used  in  this
experiment were purchased from Japan SLC Inc
(Hamamatsu,  Shizuoka,  Japan).  They were then
weighed  individually  and  divided  into  three
groups  based  on  weight.  All  rats  were  induced
with  diabetes  mellitus  by  single  intraperitoneal
injection  of  streptozotocin  at  45  mg/kg  body
weight  {2-deoxy-2  [([methylnitrosoamino]
carbonyl)amino]-D-glucopyranose (given  Sigma)
at  0.1  M  citrate  buffer  solution,  pH  4.5}.
Thereafter,  they  were  randomly  distributed  to
three  treatments  with  7  rats  assigned  to  each
treatment.  One  group  was  the  control  with  no
additive, and two-treatment groups were given the
purified  diets  supplemented  with  1%  or  2%
FCME. The rats were raised to 7 weeks of age in
individual  cages  in  an  air-conditional  room
(temperature 22+2oC with humidity  50  to 60%)
with the light on from 08:00 to 20:00. Rats were
fed  a  commercial  nonpurified  diet  (type  CE-2,
Japan Clea) for a week before the initiation of the
experiment  with purified diets.  The composition
of experimental  diets is  shown in Table 1.  Feed
and  water  were  provided  for  ad  libitum
consumption. To confirm the induction of diabetes
mellitus,  the  serum glucose level  in  the fasting
state  (16-hours  starvation)  was  determined  by
using a commercial kit  (Glucose CII-Test  Wako
kit).
Commercial  FCME  was  obtained  from
Kanzaki  Company,  Ltd.,  Takamatsu,  Japan.  The
main constituents of this extract are peptides with
20-50  chain-length  amino  acids.  This  product
contains  39,6%  moisture,  51.1%  crude  protein,
0.0% crude fat, 0.0% crude fiber, 8.7% crude ash
and 0.6% nitrogen free extract (NFE). Amino acid
profiles  of  FCME  are  published  elsewhere
(Santoso et al., 2000a).
Blood samples were drawn from tail arterial
under ether narcosis before and every weeks after
given streptozotocin,  and left  in an ice water  to
prevent  glucose  degradation.  The  serum  was
separated  from  each  blood  sample  by
centrifugation.  Simultaneously  glucose excretion
to  urine  confirmed  by  test  paper  (Testepe,
Shionogi Seiyaku Co., LTD).
At  the end of  experimental  period,  all  rats
were  weighed  individually.  Thereafter,  blood
samples were drawn from heart and removed the
liver  under  ether  narcosis.  The serum stored  at
–30oC until the determination of glucose, insulin,
total  cholesterol,  HDL-cholesterol  and  lipid
fractions.
Enzyme  assay  was  prepared  as  previously
described (Santoso et al., 1995). The activities of
key  enzymes  in  fatty  acid  synthesis  and
cholesterogenesis  were  measured.  Acetyl-
Coenzyme A carboxylase (E.C.  6.2.1.3)  activity
was assayed by H14CO3-fixation method (Qureshi
et al., 1980). Fatty acid synthetase (FAS) activity
was  assayed  by  the  1-14C-acetyl-CoA
incorporation method (HSU et al., 1965). The 3-
hydroxy-3-methylglutaryl-CoA reductase activity
was  assayed  by  the  method  of  Shefer  et  al.
(1973).  The protein content of the solution used
for enzyme assay was determined by the method
of  Lowry  et  al. (1951)  using  bovine  serum
albumin as the standard. ACC and FAS activities
were  expressed  as  nanomole  of  substrate
converted to product per minute per milligram of
protein at 37oC.  3-hydroxy-3-methylglutaryl-CoA
reductase activity was expressed as picomole of
substrate converted to product per minute per mg
protein at 38oC. Cholesterol 7-hydroxylase was
expressed as nmol/hour/mg protein. Samples were
analyzed in triplicate.
The lipid fractions  were separated by thin-
layer  chromatography  on  silica  gel  chromarod
using  hexane-diethylether-formic  acid  (60:10:1)
and hexane-benzene (1:1)  as developing  solvent
and quantified by IATROSCAN TH-10 TLC/FID
Analyzer  (Iatron  Laboratories,  Inc.,  Tokyo,
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Japan).
Concentrations  of  serum  total  cholesterol,
HDL-cholesterol were measured with commercial
kits  (Cholesterol  E  Test  Wako  Kit  and  HDL-
cholesterol E Test Wako Kit from Wako Junyaku
Kogyo Co. LTD). The difference between the total
cholesterol and HDL-cholesterol was assumed to
be  LDL+VLDL  cholesterol  (Nishizawa  and
Fudamoto,  1995).  An  atherogenic  index  was
measured using equation published by Nishizawa
and Fudamoto (1995). 
Treatment  effects  were  assessed  for  all
response  variables  using  one-way  ANOVA  in
which  the  overall  treatment  differences  were
represented  by  single  orthogonal  contrasts
between  control  and  treatment  groups  (Shinjo,
1990).
RESULTS
FCME inclusion significantly increased feed
intake (P<0.01)  and body weight  gain  (P<0.05)
FCME had no effect  on liver  weight  (Table 2).
FCME  inclusion  did  not  influence  the
concentration of serum glucose (Table 3).
The activities of acetyl-CoA carboxylase and
fatty acid synthetase were significantly lower  in
diabetic  rats fed FCME, whereas cholesterol 7
-hydroxylase  was  significantly  increased
(P<0.01).  The  activity  of  HMG-CoA reductase
was not significantly affected (Table 4).
FCME had no effect on hepatic triglyceride,
free  cholesterol  and  phospholipid.  Serum
triglyceride was significantly lower in rats fed diet
with  FCME (P<0.01),  but  total  cholesterol  and
free cholesterol were not significantly influenced.
Serum  HDL-cholesterol  was  significantly
increased (P<0.05) with lower  atherogenic index
(P<0.05).  Mackerel  extract  had  no  effect  on
LDL+VLDL-cholesterol concentration (Table 5).
Dietary  FCME had no  effect  on  serum insulin.
However, 2% FCME inclusion tended to increase
insulin concentration at 24.4% level.
DISCUSSION
An  increase  in  body  weight  gain  resulted
from higher  feed  intake  in  FCME  group.  It  is
possible  that  streptozotocin  eliminated  the
advantage of FCME in improving feed conversion
ratio. It is unkown why feed intake of diabetic rats
fed  FCME  was  higher.  Although,  there  is
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Ingredients 0% FCME 1% FCME 2% FCME
45 45 45
Sucrose 23.9 23.9 23.9
Soybean Oil 3 3 3
Casein 23 22 21
Mackerel extract 0 1 2
4 4 4
0.1 0.1 0.1
1 1 1
Total 100 100 100
Chemical Composition
Protein (%) 23 22.4 21.8
3751.6 3733.6 3715.6
ME-protein ratio 163.1 166.7 170.4
    mixture   
Table 1. Composition of Experimental Diet (%)
Corn strach
Mineral mixture1
Vitamin A & D mixture2
Vitamin B mixture3
ME (kcal/kg)
1) Supplied 650.0 g CaHPO4, 160.0 g NaCl, 140.0 g K2CO3, 32.7 g MgCO3, 10.0 g FeSO4. 7H2O, 
    3.0 g MnSO4. H2O, 1.0 g CoCl2. 6H2O, 1.0 g CuSO4, 2.0 g ZnCO3, 0.1 g KI and 0.2 g NaF per 1 kg.
2) Supplied 0.10 g ret inyl acet at e, 0.00005 g cholecalciferol and 0.8995 g corn starch per 1 gram mixture.
3) Supplied 0.083 g thiamine-HCl, 0.233 g riboflavine, 0.833 g niacin, 0.75 g Ca-pantothenate, 0.1 g 
    pyridoxine-HCl, 0.058 g folic acid, 15 g inositol, 1.667 g p-aminobenzoic acid, 0.005 g biot in, 0.004 g 
    cyanocobalamin, 33.333 g choline-HCl, 0.333 g menadione and 47.599 corn strach per 100 g mixture.
correlation  between  serum  glucose  and  feed
intake (r  = -0.93), it  appear  that the higher  feed
intake  could  not  fully  be   explained  by  lower
serum glucose concentration.  It  was  known that
FCME rich in glutamic acid, one of an active taste
compounds  in  feed  that  may  also  improve  the
palatability of diet, and therefore it increased feed
intake. As far as growth efficiency concerned, the
inclusion  of  FCME  in  diabetic  rats  had  no
beneficial  effect.  The present  results  agree with
the  observation  of  Santoso  et  al. (2000)  who
found that FCME inclusion had a little value on
improving feed efficiency in rats fed cholesterol-
containing diet.
Acetyl-CoA carboxylase was suggested as a
rate  limiting  enzyme  in  fatty  acid  synthesis
(Brindley,  1991).  Therefore,  the  reduction  of
acetyl-CoA carboxylase activity  in  diabetic  rats
fed  FCME  would  result  in  lower  fatty  acid
synthesis.  Our  previous  studies  (Santoso  et  al.,
2000,  2001)  also  found  that  FCME  inclusion
resulted  in  lower  acetyl-CoA carboxylase  and
fatty  acid  synthetase  activities  of  rats  fed  diet
without cholesterol or  those fed high-cholesterol
containing  diet.  A reduced in hepatic  fatty acid
synthesis  is  a  major  factor  which  caused  lower
hepatic  triglyceride  synthesis  (Scorve  et  al.,
1993),  and  resulting  in  lower  triglyceride
secretion into circulation. This may explain lower
serum triglyceride in diabetic rats fed 1% FCME.
It  is  unkown  however,  although  feeding  2%
FCME  reduced  hepatic  acetyl-CoA carboxylase
and fatty acid synthetase activities  it  resulted in
higher  serum triglyceride  concentration  and  no
change in hepatic triglyceride. It was known that a
major  site of  fatty acid synthesis  in rats was in
adipose tissues. Therefore, it is needed to evaluate
the activity of acetyl-CoA carboxylase and fatty
acid synthetase in adipose tissue to elucidate the
mechanism  of  different  change  in  serum
triglyceride.  In  addition,  triglyceride  clearance
from  the  circulation  by  lipoprotein  lipase  may
also contribute to this phenomenon.
A major  advance  in  the  understanding  of
cholesterol  metabolism  emerged  from  the
observation  that  in  rats  the  liver  exhibits  high
rates of cholesterol synthesis whereas  nonhepatic
tissues other than intestine show rates that are less
than 5% of those in the liver (Balasubramaman et
al.,  1976).  FCME  inclusion  did  not  reduce  the
activity  of  hepatic  HMG-CoA reductase,  a  rate
limiting  enzyme  in  cholesterol  synthesis.
Therefore, FCME inclusion might have no effect
on hepatic cholesterol synthesis. However, FCME
inclusion  might  increase  hepatic  bile  acid
synthesis as indicated by higher activity of hepatic
cholesterol  7-hydroxylase  activity,  a  rate
limiting  enzyme  in  bile  acid  synthesis.  An
increase in hepatic bile acid synthesis,  however,
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Table 2. Effects of Fermented Chub Mackerel Extract on Feed Intake, Body Weight
Gain and Feed Conversion Ratio of Diabetic Rats
Variables 0% FCME 1% FCME 2% FCME
Final body weight, g/rat
Body weight gain, g/day
Feed intake, g/day
Feed conversion ratio
Liver weight, g/100 g BW
     * Significantly different (P<0.05) from the control group.
  ** Significantly different (P<0.01) from the control group.
*** Significantly different (P<0.001) from the control group.
   194.28+6.21 209.12+5.6 218.92+ 5.4 
      3.01+0.60      3.54+0.65*      3.89+0.59*
  17.80+1.2     23.80+1.8***     24.60+2.2**
      5.91+0.05     6.72+0.06     6.32+0.05
      4.78+0.43      4.87+0.21     4.82+0.31
 Mean+SD for 7 rats
Concentration of Glucose in the Serum  of Diabetic Rats
Weeks 
0% FCM E 1% FCM E 2% FCME
0
1
2
3
4
Table 3. Effects of Fermented Chub Mackerel Extract on
after admi-
nistration
  148.9+11.51 148.9+11.5 148.9+11.5 
347.6+29.6 364.8+35.0 318.9+53.3
468.1+28.9 514.3+29.4 462.2+68.7
 475.1+23.5 461.5+25.0 448.2+37.2
554.2+82.9 536.0+41.6 520.8+29.4
Mean + SD for 7 rats
was  not  accompanied  by  neither  lower  hepatic
cholesterol nor serum total cholesterol. No change
in hepatic or serum cholesterol in rats fed FCME
was in agreement with the observation of Santoso
et al. (2001). 
A protective effect  against  the development
of  atherosclerotic  disease is  attributed  to  HDL-
cholesterol  on  the  basis  of  their  key  roles  in
reverse  cholesterol  transport  and  also  their
antioxidant properties. Badimon et al. (1990) also
found that  injection of HDL into rabbits fed on
atherogenic  diet  has  been  shown  to  inhibit
atherosclerotic  lesion  formation.  Therefore,  an
increase  in  HDL-cholesterol  with  tendency  of
lower  LDL-cholesterol  by FCME in the present
study might  have beneficial  impact on reducing
the risk of atherosclerosis. In our previous results
(Santoso  et  al.,  2000)  also  showed  that  when
FCME  was  supplemented  to  a  high-cholesterol
containing  diet,  an  increase  in  serum  HDL-
cholesterol  with  lower  LDL-cholesterol  without
any  change  in  total  cholesterol  was  observed.
Lower atherogenic index found in rats fed FCME
indicated that FCME inclusion might reduce the
risk of atherosclerosis in diabetic rats. 
FCME  had  no  antidiabetic  properties  as
indicated by no effect of FCME on serum glucose
and insulin. 
CONCLUSION
As far  as growth efficiency concerned,  the
inclusion  of  FCME  in  diabetic  rats  had  no
beneficial effect. FCME supplementation reduced
the activities  of  hepatic  acetyl-CoA carboxylase
and  fatty  acid  synthetase,  but  it  increased  the
activity of hepatic cholesterol 7-hydroxylase in
diabetic rats. FCME supplementation reduced the
risk  of  atherosclerosis  as  indicated  by  lower
atherogenic index.
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